Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5455/JPMA.20 http://scihub22266oqcxt.onion/10.5455/JPMA.20 32515379!ä!32515379 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32515379.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Pak+Med+Assoc 2020 ; 70(Suppl 3) (5): S101-S103 Nephropedia Template TP {{tp|p=32515379|t=2020. Neurological manifestations of COVID-19 |pdf=|usr=}}{{32515379}} gab.com Text Neurological manifestations of COVID-19 JO: J Pak Med Assoc http://www.kidney.de/pget.php?&tw=1&pmid=32515379 #FOAvip Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) has turned out to be a formidable pandemic. Upcoming evidence from confirmed cases of COVID-19 suggests an anticipated incursion of patients with neurological manifestations in the weeks to come. An expression of the angiotensin-converting enzyme 2 (ACE 2), the cellular receptor for SARS-CoV-2 over the glial cells and neurons have made the brain a potential target. Neurotoxicity may occur as a result of direct, indirect and post-infectious complications. Attention to neurological deficits in COVID-19 is fundamental to ensure appropriate, timely, beneficial management of the affected patients. Most common neurological manifestations seen include dizziness, headache, impaired consciousness, acute cerebrovascular disease, ataxia, and seizures. Anosmia and ageusia have recently been hinted as significant early symptoms in COVID-19. As cases with neurological deficits in COVID-19 emerge, the overall prognosis is yet unknown. Twit Text FOAVip Neurological manifestations of COVID-19 ????J Pak Med Assoc http://www.kidney.de/pget.php?&tw=1&pmid=32515379 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32515379 #FOAvip English Wikipedia <ref>{{Cite pmid|32515379}}</ref> Neurological manifestations of COVID-19 #MMPMID32515379 Kanwar D; Baig AM; Wasay M J Pak Med Assoc 2020[May]; 70(Suppl 3) (5): S101-S103 PMID32515379show ga Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) has turned out to be a formidable pandemic. Upcoming evidence from confirmed cases of COVID-19 suggests an anticipated incursion of patients with neurological manifestations in the weeks to come. An expression of the angiotensin-converting enzyme 2 (ACE 2), the cellular receptor for SARS-CoV-2 over the glial cells and neurons have made the brain a potential target. Neurotoxicity may occur as a result of direct, indirect and post-infectious complications. Attention to neurological deficits in COVID-19 is fundamental to ensure appropriate, timely, beneficial management of the affected patients. Most common neurological manifestations seen include dizziness, headache, impaired consciousness, acute cerebrovascular disease, ataxia, and seizures. Anosmia and ageusia have recently been hinted as significant early symptoms in COVID-19. As cases with neurological deficits in COVID-19 emerge, the overall prognosis is yet unknown. |*Betacoronavirus[MESH] |*Coronavirus Infections/complications/diagnosis/physiopathology[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/complications/diagnosis/physiopathology[MESH] |Angiotensin-Converting Enzyme 2[MESH] |Ataxia/virology[MESH] |COVID-19[MESH] |Headache/*virology[MESH] |Humans[MESH] |Myalgia/virology[MESH] |Peptidyl-Dipeptidase A[MESH] |SARS-CoV-2[MESH] |Seizures/virology[MESH]Neurological manifestations of COVID-19 (epmc).pdf DeepDyve Pubget Overpricing